DavidAndrewTompkinsMDMHS(He/Him)

PubMed

• 14 citations
  "I got a bunch of weed to help me through the withdrawals": Naturalistic cannabis use reported in online opioid and opioid recovery community discussion forums.
  Meredith C Meacham, Alicia L Nobles, D Andrew Tompkins, Johannes Thrul
  Plos One. 2022-01-01
• 1 citations
  Assessing the Acceptability of Yoga Among Patients with and without Chronic Pain Enrolled in a Licensed Opioid Treatment Program.
  Elnaz Ahmadi, Charlotte Evans, Gabrielle Agin-Liebes, David Andrew Tompkins
  International Journal of Yoga Therapy. 2022-01-01
• 1 citations
  National trends in testing for hepatitis C virus in licensed opioid treatment programs: Differences by facility ownership and state medicaid expansion status
  George Pro, D. Andrew Tompkins, Soraya Azari, Nickolas Zaller
  Drug and Alcohol Dependence. 2021-11-01

Journal Articles

• Prefrontal Cortex Response to Drug Cues, Craving, and Current Depressive Symptoms Are Associated with Treatment Outcomes in Methadone-Maintained Patients  
  Michael S Kidorf, D Andrew Tompkins, Nature
• Sex Differences in Measures of Central Sensitization and Pain Sensitivity to Experimental Sleep Disruption: Implications for Sex Differences in Chronic Pain  
  Traci J Speed, D Andrew Tompkins, Patrick H Finan, Sleep
• Sleep duration mediates the relationship between ethnic differences and experimental pain perception  
  McCauley L, Bond K, Bounds S, Tripp M, Buenaver L, Tompkins D, Smith M, Haythornthwaite J, Campbell C, J Pain, 4/1/2013
• Experimental pain sensitivity in opioid dependent patients: a preliminary examination of opioid-induced hyperalgesia  
  Bounds S, Campbell C, Edwards R, Smith M, Strain E, Tompkins D, J Pain, 4/1/2013
• A prospective study of withdrawal-associated hyperalgesia in opioid dependent volunteers  
  Tompkins D, Smith M, Campbell C, Strain E, J Pain, 4/1/2013
• "A double-blind, placebo-controlled trial assessing the efficacy of levetiracetam extended release in very heavy drinkers"  
  Fertig JB, Ryan ML, Falk DE, Litten RZ, Mattson ME, Ransom J, Rickman WJ, Scott C, Ciraulo D, Green AI, Ait-Daoud Tiouririne N, Johnson B, Pettinati H, Strain EC, Devi..., Alcoholism: Clin Exp Rsch, 8/1/2012
• "Treatment of gender identity disorder"  
  Byne W, Bradley SJ, Coleman E, Eyler AE, Green R, Menvielle E, Meyer-Bahlburg HF, Pleak RR, Tompkins DA, Am J Psychiatry, 8/1/2012
• "Ethnic differences in capsaicin pain response in human subjects"  
  Tripp M, McCauley L, Bond K, Simango M, Tompkins D, Edwards R, Haythornthwaite J, Campbell C, J Pain, 4/1/2012
• "Human abuse liability assessment of oxycodone combined with ultra-low-dose naltrexone"  
  Tompkins DA, Lanier RK, Harrison JA, Strain EC, Bigelow GE, Psychopharm, 7/1/2010
• "A prospective study of opioid induced hyperalgesia in healthy volunteers"  
  Tompkins D, Smith M, Bigelow G, Strain E, J Pain, 4/1/2010
• "Concurrent validation of the Clinical Opiate Withdrawal Scale (COWS) and single-item indices against the Clinical Institute Narcotic Assessment (CINA) opioid withdraw...  
  Tompkins DA, Bigelow GE, Harrison JA, Johnson RE, Fudala PJ, Strain EC, Drug Alc Dep, 11/1/2009
• "Hematological adverse events in clozapine-treated children and adolescents"  
  Gerbino-Rosen G, Roofeh D, Tompkins DA, Feryo D, Nusser L, Kranzler H, Napolitano B, Frederickson A, Henderson I, Rhinewine J, Kumra S, J Am Acad Child Adolesc Psychiatry, 10/1/2005
• Neutropenia and agranulocytosis in treatment-refractory adolescents receiving clozapine  
  Kranzler HN, Gerbino-Rosen G, Tompkins DA, Feryo D, Nussbaum L, Roofeh D, Fisch G, Frederickson A, Napolitano B, Kumra S, Schiz Bull, 4/1/2005
• "Phenotypic screening of mutations in Pmr1, the yeast secretory pathway Ca2+/Mn2+-TPase, reveals residues critical for ion selectivity and transport"  
  Wei Y, Chen J, Rosas G, Tompkins DA, Holt PA, Rao R, J Biol Chem, 8/1/2000
• Join now to see all